• Focus on oncology therapeutics.
  
  
• Emphasis on novel molecules, mechanisms of action and/or delivery systems.
  
  
• Utilization of molecularly targeted and translational research platforms to increase speed and maximize success rate.
  
  
• Strategic relationships with top cancer research and operational centers of excellence to provide a strong pipeline and efficiency.